Joyce O'Shaugnessy, MD, Texas Oncology
Advertisement
Articles by Joyce O'Shaugnessy, MD, Texas Oncology
Advertisement
Latest Updated Articles
Prognostic Tools for Early-Stage HER2+ Breast CancerPublished: January 25th 2021 | Updated:
Current Treatment Landscape for HER2+ Breast CancerPublished: January 25th 2021 | Updated:
Updated Data for Metastatic HER2+ Breast CancerPublished: January 25th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5